Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Eva Maria Urrechaga, M.D., Joins Baptist Health Heart & Vascular Care
Vascular surgeon Eva Maria Urrechaga, M.D., has joined Baptist Health Heart & Vascular Care at Baptist Health Miami Cardiac & Vascular Institute. She specializes in evaluating and treating conditions affecting the arteries and veins through open surgery and minimally invasive endovascular procedures.
Announce vascular surgeon Eva Maria Urrechaga, M.D.’s appointment at Baptist Health Miami Cardiac & Vascular Institute and summarize her training, research, and practice.
Approach:
Clinical practice: Dr. Urrechaga evaluates and treats arterial and venous conditions using open surgery and minimally invasive endovascular procedures.
Training: She completed a vascular surgery fellowship at the Hospital of the University of Pennsylvania, a seven-year general surgery residency at Jackson Memorial Hospital and the University of Miami, and a postdoctoral research fellowship in trauma, surgical critical …
Research and education: She has contributed to 28 peer-reviewed publications and presented research at regional and national medical meetings. Her research has addressed vascular injuries, limb salvage, blood clots, surgical outcomes, trauma care, and patient safety.
Key Findings:
Dr. Urrechaga has joined Baptist Health Heart & Vascular Care at Baptist Health Miami Cardiac & Vascular Institute.
She earned her medical degree from the University of Pittsburgh and her bachelor’s degree in biology from the University of Florida.
A Miami native fluent in English and Spanish, she will see patients at 8950 N. Kendall Drive, Suite 504W, Miami.
Interpretation:
The announcement describes Dr. Urrechaga’s appointment, qualifications, research background, and approach to coordinating individualized vascular care.
Limitations:
The context is an institutional appointment announcement and does not report clinical outcomes or comparative evidence.
Adults assigned to nonnutritive sweetened beverages or water maintained weight reductions through 104 weeks, with no statistically significant difference between groups.